Books and Book Chapters

      Background and History of Tobacco Genome Resources

      Sierro, N.; Ivanov, N. V.

      Date published
      Mar 17, 2020
      DOI
      10.1007/978-3-030-29493-9_1
      ISBN
      978-3-030-29493-9
      Published in
      The Tobacco Plant Genome
      Editors
      Ivanov, N. V.; Sierro, N.; Peitsch, M. C.
      Link to publication
      Topic
      Summary

      Nicotiana species, which share significant similarities with tomato, potato, eggplant, and pepper, originated in South America and subsequently spread to North America, Africa, and Australia. They are known to produce and accumulate alkaloids as part of their defense mechanism against insects and herbivores. Since their description and classification by Goodspeed in 1947, research on Nicotiana species has been ongoing, including investigations on how the genus evolved and its relationship with other Solanaceae members. The presence of diploid and polyploid species in Nicotiana and their large genome sizes resulted in the generation of multiple resources aiming at better understanding of how polyploids formed and evolved over time. The use of Nicotiana tabacum and Nicotiana benthamiana as model organisms in plant research further helped increase the interest in understanding the molecular mechanisms in these species. Here, we review the literature and summarize what is currently known about the phylogeny, cytology, and genetics of Nicotiana species. We also present the current state of the Nicotiana genomes and introduce the functional genomics insights they have provided.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.